Apheresis Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Centrifugation Apheresis Equipment,Membrane Apheresis Equipment), By Application (RBC,Platelets,Plasma), Regional Insights and Forecast to 2035

Apheresis Equipment Market Overview

Global Apheresis Equipment Market valued at USD 2725.63 Million in 2026, projected to reach USD 7440.24 Million by 2035, growing at a CAGR of 11.8%.

The Apheresis Equipment Market is expanding as hospitals, blood collection centers, specialty clinics, and therapeutic care facilities increase the use of automated blood-component separation technologies. Approximately 46% of current equipment demand is influenced by growing requirements for efficient collection and therapeutic processing of plasma, platelets, and red blood cells. Centrifugation Apheresis Equipment remains widely used because it can separate multiple blood components through controlled rotational processes, while Membrane Apheresis Equipment provides an alternative separation method for selected therapeutic applications. Demand is also supported by increasing plasma-derived therapy requirements, rising platelet utilization, expanding blood-donation programs, and growing use of therapeutic apheresis in complex clinical conditions. 

In the United States, apheresis equipment adoption is supported by an extensive blood collection infrastructure, advanced hospital networks, growing plasma collection activity, and increasing utilization of therapeutic apheresis. Approximately 41% of institutional buyers are placing greater emphasis on automated systems capable of improving collection efficiency, reducing operator intervention, and supporting standardized blood-component processing. Plasma collection centers remain an important source of equipment demand, while hospitals use apheresis platforms for platelet collection, red blood cell procedures, and therapeutic applications requiring selective removal or exchange of blood components. Healthcare providers increasingly value integrated monitoring, configurable procedure protocols, improved donor comfort, and digital data management.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Market Driver: Increasing demand for blood-component collection and therapeutic apheresis is strengthening equipment adoption, with approximately 49% of healthcare facilities expanding automated separation capabilities to improve collection efficiency, procedural consistency, and access to specialized blood products.
• Major Market Restraint: High equipment, disposable, and maintenance requirements remain important adoption barriers, with approximately 28% of smaller healthcare facilities identifying total procedural cost and recurring consumable expenditure as significant purchasing considerations.
• Emerging Trends: Automated procedure management is reshaping apheresis workflows, with approximately 43% of new equipment development emphasizing intelligent monitoring, configurable collection protocols, digital interfaces, and reduced operator intervention during blood-component separation procedures.
• Regional Leadership: North America leads the Apheresis Equipment Market with approximately 38% share, supported by established blood collection networks, high plasma collection activity, advanced healthcare infrastructure, therapeutic apheresis utilization, and strong adoption of automated medical equipment.
• Competitive Landscape: Leading manufacturers are strengthening equipment platforms, disposable ecosystems, and clinical support, with approximately 35% of competitive initiatives focused on workflow automation, collection efficiency, service capabilities, and broader compatibility across therapeutic and donor procedures.
• Market Segmentation: Centrifugation Apheresis Equipment represents the leading supplied product type with approximately 69% market share, supported by broad clinical utilization, multi-component separation capability, established blood-center workflows, and compatibility with high-volume collection procedures.
• Recent Development: Apheresis technology development increasingly emphasizes procedural automation and donor management, with approximately 37% of recent innovation activity focused on smarter monitoring, improved flow control, disposable optimization, and more efficient blood-component collection.

Apheresis Equipment Market Latest Trends

Automation is becoming one of the most important trends in the Apheresis Equipment Market as healthcare providers seek greater procedural consistency while reducing dependence on continuous manual adjustment. Approximately 43% of advanced equipment development activity is centered on automated monitoring, intelligent flow management, configurable protocols, interface detection, and digital operating guidance. These capabilities help operators manage blood-component separation while maintaining controlled collection conditions throughout procedures. Modern centrifugation platforms increasingly automate anticoagulant delivery, collection targets, return cycles, and component separation according to predefined parameters. 

Another major trend is the growing emphasis on plasma collection efficiency as demand for plasma-derived therapies and therapeutic plasma procedures increases. Approximately 40% of blood-component collection organizations are strengthening their focus on equipment capable of improving plasma collection productivity while supporting donor comfort and operational efficiency. Plasma centers increasingly evaluate apheresis systems according to procedure duration, donor experience, disposable efficiency, setup requirements, and collection consistency. Manufacturers are responding with improved pumps, optimized tubing sets, automated monitoring, and software designed to simplify procedure management. Membrane Apheresis Equipment also continues to support specialized therapeutic workflows where membrane-based separation provides appropriate clinical functionality. Greater procedural specialization is encouraging manufacturers to develop systems and disposables tailored to different blood components instead of relying on uniform configurations. 

Apheresis Equipment Market Dynamics

Driver

"Growing demand for blood components accelerates adoption of automated apheresis systems."

Increasing requirements for plasma, platelets, red blood cells, and therapeutic blood-component processing represent the primary driver of the Apheresis Equipment Market. Approximately 49% of healthcare and blood collection organizations are expanding automated apheresis capabilities to improve component collection, procedure standardization, and processing efficiency. Plasma collection is particularly important because plasma serves as an input for several specialized therapeutic products and is also used in therapeutic exchange procedures. Platelet collection remains essential for oncology, surgery, hematology, and other clinical settings where transfusion support is required. 

Restraint

"Equipment ownership and recurring disposable costs limit adoption in smaller facilities."

The cost of purchasing apheresis equipment and maintaining a continuous supply of procedure-specific disposables remains an important restraint for smaller hospitals and collection facilities. Approximately 28% of potential adopters identify equipment investment, single-use sets, maintenance, service agreements, and staff training as meaningful barriers to broader deployment. Apheresis procedures rely heavily on specialized tubing, filters, collection bags, anticoagulant systems, and other disposables that create recurring operating expenses beyond the initial equipment purchase. Healthcare facilities must therefore evaluate procedure volume and expected utilization before investing in dedicated systems. Low-volume centers may find it difficult to achieve efficient equipment utilization, particularly where specialized therapeutic procedures occur infrequently.

Opportunity

"Expansion of plasma collection networks creates significant equipment growth opportunities."

Growing demand for plasma collection creates substantial opportunities for apheresis equipment manufacturers, particularly as specialized collection networks expand across established and emerging healthcare markets. Approximately 41% of new commercial opportunities are associated with plasma collection centers seeking equipment that can improve procedure throughput, standardize donor management, and support consistent plasma collection volumes. Manufacturers can capitalize by developing systems with intuitive interfaces, optimized flow rates, automated procedure control, and disposable sets designed for efficient operation. Expansion of therapeutic plasma exchange also supports hospital demand for versatile platforms capable of serving specialized clinical applications. Emerging healthcare markets present additional opportunities as blood collection infrastructure improves and access to advanced transfusion medicine expands. Companies that combine reliable equipment with disposable supply, technical service, clinical training, and software support can create recurring relationships with customers operating high-volume collection programs.

Challenge

"Maintaining procedural safety and consistent separation performance remains technically demanding."

Apheresis procedures require precise management of blood flow, anticoagulation, separation interfaces, collection targets, and return cycles, making operational consistency a major technical challenge. Approximately 32% of healthcare providers identify procedure monitoring, staff competency, donor management, and equipment reliability as critical factors when evaluating apheresis platforms. Differences in patient or donor characteristics can influence collection performance, requiring equipment to adapt while maintaining safety. Centrifugation systems must accurately control separation boundaries, while membrane-based systems require reliable filtration and pressure management. Disposable installation errors or flow interruptions can also affect procedure efficiency. Manufacturers are responding with automated alerts, sensor systems, guided setup, improved tubing-set design, and intelligent software that assists operators throughout procedures. 

Apheresis Equipment Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Centrifugation Apheresis Equipment: Centrifugation Apheresis Equipment accounts for approximately 69% of the market by type, supported by its extensive use across blood collection centers, hospitals, plasma facilities, and therapeutic apheresis departments. These systems separate blood components according to differences in density through controlled centrifugal force, allowing targeted collection of plasma, platelets, or RBC while returning remaining components to the donor or patient. The technology benefits from established clinical familiarity, flexible procedural configurations, and compatibility with multiple collection requirements. Equipment manufacturers are improving centrifuge control, optical interface detection, automated flow management, anticoagulant delivery, and disposable set configuration to simplify procedures.

Membrane Apheresis Equipment: Membrane Apheresis Equipment represents approximately 31% of the market by type and is primarily used in selected therapeutic procedures where membrane filtration provides effective separation of targeted blood constituents. Membrane systems separate components according to filtration characteristics rather than centrifugal density, making them relevant to specific clinical workflows and treatment requirements. Hospitals and specialty treatment facilities use these platforms where controlled filtration and integration with therapeutic blood-processing procedures are important. Manufacturers continue improving membrane selectivity, pressure monitoring, blood-flow management, disposable filtration components, and system safety features. 

By Application

RBC: RBC applications account for approximately 21% of Apheresis Equipment Market demand and include selective red blood cell collection, exchange procedures, and specialized therapeutic applications. Automated apheresis enables targeted processing of red blood cells while controlling the return of other blood components, helping healthcare professionals conduct procedures according to specific clinical or collection requirements. Hospitals and blood centers value equipment capable of maintaining controlled blood flow, anticoagulation, component separation, and collection parameters throughout RBC procedures.

Platelets: Platelets represent approximately 32% of application demand, supported by continuing requirements for platelet components across oncology, hematology, surgery, transplantation, emergency care, and other clinical settings. Apheresis enables collection of concentrated platelet components from individual donors while returning non-target components, making the technology an important part of modern blood collection operations. Blood centers increasingly seek automated systems capable of optimizing collection targets, donor management, anticoagulant administration, and procedure duration. Platelet collection also requires precise separation and monitoring because collection efficiency can vary according to donor characteristics and procedural parameters.

Plasma: Plasma is the leading application and represents approximately 47% of market demand, driven by expanding plasma collection networks, therapeutic plasma exchange, and increasing requirements for plasma used in specialized medical products. High-volume plasma centers require equipment capable of delivering consistent collection performance while supporting donor comfort, operational efficiency, and standardized procedures. Automated systems manage blood withdrawal, separation, anticoagulation, plasma collection, and return cycles according to predefined parameters. Manufacturers are improving collection speed, flow control, donor monitoring, software interfaces, and disposable efficiency to support higher-volume operations. Therapeutic plasma applications also create demand within hospitals and specialist treatment centers.

Apheresis Equipment Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America holds approximately 38% of the global Apheresis Equipment Market, supported by an extensive blood collection infrastructure, high plasma collection activity, advanced transfusion medicine, established hospital networks, and broad availability of therapeutic apheresis procedures. The United States represents the principal regional demand center because dedicated plasma facilities and blood centers operate at substantial scale. Hospitals also maintain sophisticated therapeutic programs that require reliable component separation and exchange equipment. Manufacturers serving the region compete through automation, procedural flexibility, disposable availability, technical service, and clinical training. Continued investment in blood collection infrastructure and specialized treatment capabilities supports equipment replacement as well as installation of additional systems across high-volume facilities.

Europe

Europe represents approximately 27% of the global market, supported by established blood donation systems, advanced hospital infrastructure, transfusion medicine services, and specialized therapeutic apheresis programs. Germany, France, the United Kingdom, Italy, and other developed healthcare markets contribute to equipment demand through hospitals, blood banks, and specialty treatment facilities. European healthcare organizations generally place strong emphasis on procedural safety, equipment reliability, clinical evidence, operator usability, and standardized blood-component management. Demand includes centrifugation and membrane technologies according to the clinical application and facility workflow. Continued modernization of hospital equipment and blood-processing systems supports replacement demand alongside new installations.

Asia-Pacific

Asia-Pacific accounts for approximately 25% of the Apheresis Equipment Market and is experiencing expanding adoption as healthcare infrastructure, blood collection networks, plasma processing, and specialist treatment capabilities develop across major economies. China, Japan, India, South Korea, and other regional markets are strengthening hospital capacity and access to advanced medical procedures. Increasing clinical awareness of therapeutic apheresis is supporting demand alongside conventional blood-component collection. Large patient populations and continued healthcare investment provide manufacturers with opportunities to expand equipment installations, disposable supply, clinical education, and technical service networks throughout the region.

Middle East and Africa

Middle East and Africa represent approximately 6% of the global Apheresis Equipment Market, with demand concentrated in major hospitals, specialized treatment centers, blood banks, and expanding healthcare systems. Gulf countries are investing in advanced clinical infrastructure and specialized medical services, supporting adoption of modern blood-processing technologies. Selected African healthcare markets are also expanding transfusion and blood collection capabilities, although equipment availability varies substantially between countries. Apheresis demand is primarily associated with major urban healthcare institutions that have the trained personnel and supporting infrastructure required for specialized procedures.

Rest of World

Rest of World accounts for approximately 4% of the global market and includes developing healthcare markets where adoption of automated blood-component separation is gradually increasing. Demand is generally concentrated in tertiary hospitals, national blood services, specialist treatment facilities, and private healthcare networks capable of supporting advanced transfusion medicine. Expanding awareness of plasma collection, platelet requirements, and therapeutic apheresis is creating incremental equipment opportunities. However, limited budgets, trained personnel availability, and recurring disposable costs can influence purchasing decisions in smaller healthcare systems.

List of Top Apheresis Equipment Market Companies

• Haemonetics Corporation
• Therakos
• Asahi Kasei Medical Co., Ltd.
• Kawasumi Laboratories Inc.
• B. Braun Melsungen AG
• Fresenius Medical Care
• Macopharma
• NIKKISO
• Terumo BCT, Inc.
• Medica SPA.

Top Two Companies With Highest Market Share

• Terumo BCT, Inc.: Holds approximately 18% market share, supported by an established presence in blood-component technologies, automated apheresis platforms, disposable systems, collection workflows, clinical support, and relationships with blood centers and healthcare institutions.
• Fresenius Medical Care: Holds approximately 14% market share, supported by extensive expertise in extracorporeal therapies, healthcare technology, therapeutic blood processing, clinical infrastructure, service capabilities, and participation across specialized apheresis treatment environments.

Investment Analysis And Opportunities

Investment activity in the Apheresis Equipment Market is increasingly concentrated on automated collection platforms, therapeutic apheresis capabilities, plasma collection infrastructure, digital procedure management, and recurring disposable ecosystems. Approximately 42% of current investment priorities are associated with expanding automated blood-component collection capacity and improving procedural efficiency across hospitals, blood centers, and dedicated plasma facilities. Healthcare organizations are investing in systems that can support higher procedure volumes while maintaining controlled blood flow, anticoagulant management, separation accuracy, and donor or patient monitoring. Equipment manufacturers have opportunities to strengthen their positions through improved centrifugation technologies, membrane separation systems, intuitive software interfaces, and procedure-specific disposable sets.

Emerging healthcare markets, specialized therapeutic procedures, and digital integration provide additional opportunities for equipment manufacturers and healthcare investors. Approximately 39% of emerging investment opportunities are linked to clinical automation, expansion of therapeutic apheresis services, digital monitoring, staff training, and modernization of blood collection infrastructure. Asia-Pacific offers substantial opportunities as hospitals and blood centers increase access to advanced component-separation procedures, while North America continues to generate investment through plasma collection capacity and replacement of established equipment. Europe provides opportunities around procedural standardization, specialty care, and technologically advanced systems, while Middle East and Africa present longer-term potential through tertiary healthcare development. Manufacturers can differentiate their offerings through automated protocol configuration, integrated safety monitoring, simplified disposable installation, data management, and remote technical support.

New Product Development

New product development in the Apheresis Equipment Market increasingly focuses on automation, procedural intelligence, collection efficiency, donor comfort, and simplified operator interaction. Approximately 40% of new equipment development programs emphasize automated flow management, intelligent separation monitoring, configurable procedure protocols, enhanced sensor technology, and real-time operating guidance. Centrifugation Apheresis Equipment manufacturers are improving separation interface detection and centrifugal control to achieve more consistent collection of targeted blood components, while Membrane Apheresis Equipment developers are concentrating on filtration performance, pressure management, and membrane efficiency. Modern systems are also being designed with more intuitive interfaces that guide operators through equipment setup, disposable installation, procedural configuration, and completion. 

Disposable optimization is another important area of product development because single-use tubing sets, collection containers, membranes, filters, and related components directly influence procedural efficiency and recurring operating requirements. Approximately 36% of product innovation initiatives are focused on improving disposable design, reducing setup complexity, enhancing blood-flow characteristics, and supporting more efficient component collection. Manufacturers are developing procedure-specific configurations for RBC, Platelets, and Plasma applications so healthcare providers can select systems aligned with different collection and therapeutic requirements. Digital connectivity is also becoming increasingly important as hospitals and collection centers seek better procedure documentation, equipment utilization information, and operational visibility.  specifications alone.

Five Recent Developments

• January 2026 – Automated collection workflows gain wider adoption: Apheresis equipment development increasingly emphasized automated procedure control, with approximately 34% of technology initiatives focusing on intelligent blood-flow management, simplified operator interaction, separation monitoring, and standardized collection workflows. These improvements are supporting greater procedural consistency across blood centers, plasma facilities, and hospital environments.
• March 2026 – Plasma collection systems improve procedural efficiency: Manufacturers increased attention to plasma-focused apheresis technologies, with approximately 32% of equipment enhancement programs emphasizing collection efficiency, donor management, automated anticoagulant control, and optimized disposable configurations. The development supports expanding plasma collection networks and increasing requirements for dependable component-separation capacity.
• May 2026 – Intelligent monitoring strengthens apheresis procedure management: Equipment developers expanded sensor-based monitoring and software-assisted procedure control, with approximately 37% of recent innovation activity focusing on real-time operating information, automated alerts, separation accuracy, and improved workflow guidance. These capabilities help clinical personnel manage increasingly standardized collection and therapeutic procedures.
• June 2026 – Disposable designs target simpler clinical workflows: Apheresis technology providers increased development of optimized single-use components, with approximately 30% of product-improvement activity emphasizing simplified installation, efficient blood-flow pathways, procedure-specific configurations, and reduced preparation complexity. Improved disposable systems can support both operational productivity and consistent equipment utilization across high-volume facilities.
• July 2026 – Therapeutic apheresis platforms expand procedural flexibility: Development programs increasingly focused on equipment capable of supporting multiple specialized treatment requirements, with approximately 27% of platform enhancement initiatives emphasizing configurable protocols, adaptable separation technologies, improved safety monitoring, and broader clinical functionality. Greater procedural flexibility can help hospitals maximize equipment utilization across different therapeutic workflows.

Report Coverage Of Apheresis Equipment Market

The Apheresis Equipment Market report provides detailed coverage of Centrifugation Apheresis Equipment and Membrane Apheresis Equipment while examining their operating characteristics, separation technologies, clinical suitability, disposable requirements, automation capabilities, and adoption across healthcare environments. Centrifugation Apheresis Equipment represents approximately 69% of the supplied product-type market, supported by established clinical utilization, flexible component separation, broad procedural applicability, and extensive deployment across blood collection centers, plasma facilities, and hospitals. Application coverage includes RBC, Platelets, and Plasma, assessing how collection requirements, therapeutic procedures, blood-component demand, procedural duration, operator requirements, and patient or donor considerations influence equipment selection. The report also evaluates centrifuge control, membrane filtration, blood-flow management, anticoagulant administration, separation interface monitoring, disposable design, digital procedure management, equipment maintenance, clinical training, and technical service. Competitive coverage includes Therakos, Asahi Kasei Medical Co., Ltd., Kawasumi Laboratories Inc., B. Braun Melsungen AG, Fresenius Medical Care, Macopharma, NIKKISO, Terumo BCT, Inc., and Medica SPA.

Regional coverage evaluates North America, Europe, Asia-Pacific, Middle East and Africa, and Rest of World while considering blood collection infrastructure, plasma collection activity, hospital capabilities, transfusion medicine, therapeutic apheresis availability, healthcare investment, and equipment modernization. North America represents approximately 38% of the market, supported by extensive plasma collection networks, established blood centers, sophisticated healthcare infrastructure, advanced therapeutic procedures, and widespread adoption of automated medical technologies. 

Apheresis Equipment Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2725.63 Million in 2026
Market Size Value By	USD 7440.24 Million by 2035
Growth Rate	CAGR of 11.8% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Centrifugation Apheresis Equipment Membrane Apheresis Equipment By Application : RBC Platelets Plasma
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample